Categorie -wet- en regelgeving

bv CGR, GDPR

wet- en regelgeving

Ipsen’s Cabometyx gains European approval in hepatocellular carcinoma

19 november 2018

InPharm.com

wet- en regelgeving

Amgen gets EMA committee positive opinion to expand use of Blincyto in patients with minimal residual disease-positive B-cell precursor ALL

19 november 2018

Pharma Biz

wet- en regelgeving

Abbott introduces new DRG Invisible Trial System for chronic pain management

19 november 2018

Pharma Biz

wet- en regelgeving

FDA declines to approve Aquestive’s Viagra rival

19 november 2018

Reuters Health

wet- en regelgeving

US FDA grants priority review status to Roche’s Tecentriq in combo with Abraxane to treat people with PD─L1─positive, metastatic triple─negative breast cancer

15 november 2018

Pharma Biz

wet- en regelgeving

Keytruda Gets FDA Approval for Hepatocellular Carcinoma

13 november 2018

Monthly Prescribing Reference (MPR): Drug News

Medhc-fases-banner

Advertentie(s)

Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer